Severe Combined Immune Deficiency (SCID) and Combined Immune Deficiency (CID)
Understanding SCID and CID
SCID is characterized by an absence of T-cells and little or no B-cell function. CID is characterized by impaired T-cell and B-cell function, although T-cells and B-cells are not absent. SCID and CID are inherited disorders - children inherit the gene from their parents. CID is similar to SCID but is a less serious and aggressive form of primary immune deficiency.
Symptoms of SCID and CID
Symptoms of both SCID and CID include frequent and severe respiratory infections. Other symptoms, which occur in infants, include poor growth, rashes similar to eczema, recurrent thrush in the mouth, chronic diarrhea, though all these symptoms may not occur.
Diagnosing SCID and CID
Since 2018 all states in the U.S and Washington, DC and Puerto Rico screen newborns for SCID as a part of routine newborn screening. Screening for SCID measures a component of DNA, the T-cell receptor excision circle (TREC). Screening at birth affords the opportunity to identify and treat SCID before the onset of symptoms. Most states also screen for CID at birth with a blood test that measures lymphocytes (a type of white blood cell) in the blood.
Treating SCID and CID
Immune globulin therapy administered into the blood stream intravenously (IVIG) is given to infants with SCID and CID along with prophylactic antibiotics, antivirals, and antifungals. Some patients may receive immune globulin therapy administered under the skin subcutaneously (SCIG). Immune globulin therapy will not restore the function of the deficient T-cells; however, it restores antibodies that are missing, resulting from the B-cell defect, which is beneficial to the patient. The most accepted treatment for both SCID and CID is bone marrow or stem cell transplant which is curative.
This content is not intended to substitute professional medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
At Nufactor, we are committed to providing our patients the education, support and resources necessary to complete your IVIG treatment successfully and with the desired outcomes. Please contact us with any further questions.